Guilford (GLFD) - Steadily Rising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Guilford (GLFD) - Steadily Rising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Russian Bear who wrote (63)	8/22/1997 9:27:00 AM
From: SteveG	of 496

<There probably wasn't any new information released on Gliadel sales, was there?> No sales figures on the call that I heard, but one report by AB's Kevin Tang I saw broke down (factoring a 15% discount to royalties, with RPR) are $11/share, with a "absolute" cap of $241MM. Dopascan (applying a 20% discount) is modeled at $2/share, absolute $47MM. I hoping to get other analyst's comments... anyone else hear any? S

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next